The new cleanroom at our global headquarters in Salt Lake City, Utah, was designed for today's rigorous contamination control expectations, driven by EU GMP Annex 1. Learn More
Scott Sutton, PhD, was a well-respected and influential thought leader in the microbiology industry. He was a consultant and trainer in CGMP, investigations, environmental monitoring, and contamination control for pharmaceutical companies for over 30 years. He gave many presentations on...
The landscape of biocompatibility assessment of medical devices is an ever-changing and evolving one. Recently, there has been a lot of effort put into the development of alternatives to in vivo biocompatibility testing. Expanding technological capability and increased scientific understanding...
Scientists at Nelson Laboratories recently returned from presenting new in vitro research at the 2015 Society of Toxicology (SOT) annual meeting with news that the future of in vitro testing of medical devices in the United States looks bright, and...
Nelson Laboratories President and CEO Jeffery Nelson recently met with MDTmag’s Sean Fenske to discuss the future of the MedTech industry. The following is an excerpt from that interview in which Nelson highlights the state of medical device testing in light...
For the MedTech industry there was a mixed bag of results, innovation and regulatory changes. Venture capital has not returned to pre-2008 levels in most medical technology sectors, the medical device tax in the United States was widely debated by...
